[EN] FUSED HETEROCYCLIC KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE HETEROCYCLIQUES ACCOLES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2006004636A2
公开(公告)日:2006-01-12
In general, the instant invention comprises compounds of Formulas (I) and (II) including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.